A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
Clinical trial NCT06254612 · COMPLETED
Trial details
- NCT number
- NCT06254612
- Sponsor
- Sirtsei Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2026-07-08
- Enrollment
- 497
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.